1. Home
  2. BMRA vs PFSA Comparison

BMRA vs PFSA Comparison

Compare BMRA & PFSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Biomerica Inc.

BMRA

Biomerica Inc.

HOLD

Current Price

$2.66

Market Cap

7.7M

Sector

Health Care

ML Signal

HOLD

PFSA

Profusa Inc.

N/A

Current Price

$0.10

Market Cap

7.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BMRA
PFSA
Founded
1971
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.7M
7.1M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BMRA
PFSA
Price
$2.66
$0.10
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
149.2K
52.8M
Earning Date
01-14-2026
02-20-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$4,457,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
122.22
52 Week Low
$2.11
$0.07
52 Week High
$10.16
$12.76

Technical Indicators

Market Signals
Indicator
BMRA
PFSA
Relative Strength Index (RSI) 49.31 N/A
Support Level $2.56 N/A
Resistance Level $2.79 N/A
Average True Range (ATR) 0.20 0.00
MACD -0.00 0.00
Stochastic Oscillator 42.02 0.00

Price Performance

Historical Comparison
BMRA
PFSA

About BMRA Biomerica Inc.

Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. The Company manages its operations as a single operating and reportable segment, which focus on the development, manufacture, marketing, and sale of diagnostic products. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.

About PFSA Profusa Inc.

Profusa Inc is a clinical-stage digital health and medical technology company focused on developing biosensing solutions to improve health outcomes for patients with a variety of different diseases and conditions. The Company's technology enables the development of bioengineered sensors that are designed to become one with the body to detect and continuously transmit actionable, clinical-grade data for personal and medical use. The Company's first offering in the European Union, the Lumee Oxygen Platform, is designed to report reliable tissue oxygen levels at various regions of interest, both acutely and long-term.

Share on Social Networks: